SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+6.87%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$269M
AUM Growth
+$269M
(-8.1%)
Cap. Flow
-$28.2M
Cap. Flow
% of AUM
-10.48%
Top 10 Holdings %
Top 10 Hldgs %
26.22%
Holding
94
New
17
Increased
21
Reduced
26
Closed
21
Top Buys
| 1 |
HCA Healthcare
HCA
|
$7.47M |
| 2 |
Universal Health Services
UHS
|
$6.8M |
| 3 |
Viatris
VTRS
|
$5.08M |
| 4 |
Bristol-Myers Squibb
BMY
|
$4.6M |
| 5 |
Johnson & Johnson
JNJ
|
$4.19M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$8.51M |
| 2 |
Agilent Technologies
A
|
$6.74M |
| 3 |
Gilead Sciences
GILD
|
$6.48M |
| 4 |
AET
Aetna Inc
AET
|
$6.31M |
| 5 |
Revvity
RVTY
|
$6.21M |
Sector Composition
| 1 | Healthcare | 92.84% |
| 2 | Financials | 1.34% |
| 3 | Energy | 1.14% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Chemed
CHE
$6.67B
| $2.43M | 0.9% |
10,000
-2,500
| -20% | -$608K |
|
|
CLVS
52
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.38M | 0.88% |
35,000
+5,000
| +17% | +$340K |
|
53
Edwards Lifesciences
EW
$47.8B
| $2.25M | 0.84% |
+20,000
| New | +$2.25M |
|
|
AVXS
54
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.21M | 0.82% |
+20,000
| New | +$2.21M |
|
|
KND
55
DELISTED
Kindred Healthcare
KND
| $2.18M | 0.81% |
225,000
+199,037
| +767% | +$1.93M |
|
56
Bausch Health
BHC
$2.74B
| $2.08M | 0.77% |
100,000
-75,000
| -43% | -$1.56M |
|
|
TSRO
57
DELISTED
TESARO, Inc.
TSRO
| $2.07M | 0.77% |
25,000
+15,000
| +150% | +$1.24M |
|
|
DPLO
58
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $2.01M | 0.74% |
+100,000
| New | +$2.01M |
|
59
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.96M | 0.73% |
65,000
-55,000
| -46% | -$1.66M |
|
|
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.95M | 0.72% |
40,000
+15,000
| +60% | +$730K |
|
61
Sarepta Therapeutics
SRPT
$1.78B
| $1.67M | 0.62% |
+30,000
| New | +$1.67M |
|
|
JUNO
62
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.6M | 0.59% |
35,000
-20,000
| -36% | -$914K |
|
|
BPMC
63
DELISTED
Blueprint Medicines
BPMC
| $1.51M | 0.56% |
+20,000
| New | +$1.51M |
|
|
LOXO
64
DELISTED
Loxo Oncology, Inc
LOXO
| $1.47M | 0.55% |
17,500
-7,500
| -30% | -$631K |
|
|
SGEN
65
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.47M | 0.55% |
27,500
-2,500
| -8% | -$134K |
|
66
Agios Pharmaceuticals
AGIO
$2.19B
| $1.14M | 0.42% |
+20,019
| New | +$1.14M |
|
|
67
Agilent Technologies
A
$35.7B
| – | – |
-105,000
| Closed | -$6.74M |
|
|
AMED
68
DELISTED
Amedisys
AMED
| – | – |
-55,000
| Closed | -$3.08M |
|
69
Bruker
BRKR
$5.16B
| – | – |
-50,000
| Closed | -$1.49M |
|
70
Quest Diagnostics
DGX
$20.3B
| – | – |
-20,000
| Closed | -$1.87M |
|
71
Danaher
DHR
$147B
| – | – |
-55,000
| Closed | -$4.72M |
|
72
Encompass Health
EHC
$12.3B
| – | – |
-50,912
| Closed | -$2.36M |
|
|
73
Gilead Sciences
GILD
$140B
| – | – |
-80,000
| Closed | -$6.48M |
|
74
Idexx Laboratories
IDXX
$51.8B
| – | – |
-17,500
| Closed | -$2.72M |
|
75
Merck
MRK
$210B
| – | – |
0
| – | – |
|